Did you miss the part where he explained how the IPSC 'risks' you lot are so obsessed with are mitigated with fail-safe manufacturing processes? Did you miss the part where he outlined how this IPSC-to-MSC conversion process has been validated by regulators across the globe, which enabled the clinical trials to be conducted worldwide? Did you also miss the other part where he explains how the culturing process tissue-derived products (like bone marrow) go through 'ages' the cells and decreases their effectiveness, and how IPSC derived MSCs do not require this?
10 to the power of 76.
Add to My Watchlist
What is My Watchlist?
